Actively Recruiting
European Study on Early and Symptomatic Normal Pressure Hydrocephalus iNPH Tracking Imaging, Biomarkers, and Surgical Outcomes
Led by Johan Virhammar · Updated on 2026-04-30
140
Participants Needed
7
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying Normal Pressure Hydrocephalus NPH, focusing on the early stage called prodromal iNPH, to understand how it progresses into symptomatic NPH. The study aims to predict this progression by using advanced brain imaging and analyzing biomarkers found in cerebrospinal fluid CSF and blood plasma. It will also explore the unknown processes causing deterioration in patients by tracking changes over time. The study involves three groups patients with early signs but mild or no symptoms, healthy controls, and patients with symptomatic NPH. Participants in the prodromal group will undergo brain MRI scans, lumbar punctures to collect CSF, and blood samples at baseline and at regular intervals over up to six years. Their symptoms will be assessed repeatedly, especially if they progress and require shunt surgery. Healthy controls will follow the same assessment schedule but only for one cycle up to four years. Symptomatic patients will be age-matched and followed for five years after shunt surgery with clinical evaluations and blood tests. Throughout the study, participants will have multiple visits for symptom assessments, imaging, and sample collections. Researchers will measure outcomes such as the frequency of progression to symptomatic NPH requiring surgery, changes in brain structure, biomarker levels, and quality of life. Post-operative improvements in symptoms will also be tracked over five years. The total participation duration varies depending on group assignment and progression of symptoms.
CONDITIONS
Brief Title
European Study of Prodromal iNPH
Research Team
J
Johan Virhammar, MD, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here